Bronchoscopic Re-biopsy for Mutational Analysis of Non-small Cell Lung Cancer

Conclusion This study shows that bronchoscopic re-biopsy for NSCLC is feasible and provides adequate samples that enable identification of resistance mutations and rare driver oncogenes.

http://link.springer.com/10.1007/s00408-016-9864-5

Source: Lung - March 7, 2016 Category: Respiratory Medicine Source Type: research